Iambic shares rise 16% in debut after $150 million US IPO

Iambic Therapeutics Inc. raised $150 million in a US initial public offering.
Iambic shares traded at $18.50 as of 12:21 p.m. in New York on Thursday, after trading was paused for volatility, above the $16 IPO price.

Sources